Follow
Direct Oral Anticoagulants (DOACs)
Direct oral anticoagulants (DOACs) is the generic term for a group of anticoagulating substances that act directly against certain coagulation factors and can be taken orally (or by mouth). Traditional anticoagulants such as warfarin, coumarin and heparin are in widespread use.
APR 22, 2020 | 8:00 AM
C.E. CREDITS
Discover strategies for labs to optimize coagulation testing, improve patient outcomes, and strengthen their role in clinical care teams....
APR 20, 2020 | 8:00 AM
C.E. CREDITS
Explore emergency hemostasis testing approaches, from rapid lab assays to viscoelastic methods, for managing bleeding patients....
FEB 05, 2020 | 8:00 AM
C.E. CREDITS
Learn how new hemophilia and anticoagulant therapies impact coagulation assays and clinical decisions in our educational session....
APR 22, 2019 | 12:00 AM
C.E. CREDITS
Explore how DOACs impact routine coagulation assays and learn lab strategies for managing patients in critical care situations....
NOV 08, 2017 | 6:00 AM
Monitoring unfractionated heparin (UFH) using the activated partial thromboplastin time (APTT) or the anti-factor Xa (anti-Xa) chromogenic assay still seems to be a controversy. Is the...
APR 26, 2017 | 6:00 AM
C.E. CREDITS
Learn how DOACs affect lab assays and strategies for managing hospitalized patients needing bridging anticoagulation in our educational webinar....
FEB 05, 2020 | 8:00 AM
C.E. CREDITS
Learn how new hemophilia and anticoagulant therapies impact coagulation assays and clinical decisions in our educational session....
APR 22, 2019 | 12:00 AM
C.E. CREDITS
Explore how DOACs impact routine coagulation assays and learn lab strategies for managing patients in critical care situations....
NOV 08, 2017 | 6:00 AM
Monitoring unfractionated heparin (UFH) using the activated partial thromboplastin time (APTT) or the anti-factor Xa (anti-Xa) chromogenic assay still seems to be a controversy. Is the...